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Iron metabolism was examined in 15 bovine leukemia virus (BLV)-infected dairy cows
(2.6–7.8 years old). BLV infection was detected by measuring serum antibody titer against
BLV virus antigen (gp51). The anti-BLV antibody titers of the BLV-infected cows were
significantly higher in serum than in milk; a single serum-positive animal lacked detectable
anti-BLV antibodies in its milk. Iron and ferritin concentrations also were significantly higher
in serum than in milk. Although most of the BLV-infected dairy cows had past or present
anamneses (such as inflammatory diseases, including intramammary infection), the milk
ferritin concentrations of the infected cows were significantly lower than those of normal
cows; serum ferritin concentrations did not differ significantly between these two groups.
The anti-BLV antibody titers in milk samples showed significant correlation with serum
iron concentrations. These results suggest that BLV infection affects iron homeostasis
through iron metabolism in the dairy cow mammary gland.
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Introduction
Bovine leukosis is classified into two types: sporadic bovine leukosis (SBL, characterized by T-cell
leukosis) and enzootic bovine leukosis (EBL, characterized by B-cell leukosis) (1–5). EBL, which
occurs at a much higher frequency than SBL, and is an infectious disease caused by bovine leukemia
virus (BLV) (4). This virus belongs to the genusDeltaretrovirus in the family Retreviridae (1, 3). BLV
infection affects cellular functions in transcription, translation, RNAprocessing, signal transduction,
cell growth, apoptosis, stress response, and immune response (3, 6–12). BLV is a unique retrovirus
related to human T-cell leukemia virus type 1 (HTLV-1), which is a causative agent of adult T-cell
leukemia (1, 13). In the BLV and HTLV-1 systems, cell transformation may be the result of the
expression of the Tax protein (5, 6, 13). Molecular understanding of the leukemogenesis induced
by BLV infection may provide insights for the development of novel and effective antiretroviral
therapeutics applicable for HTLV (1).
Bovine leukemia virus infection is frequently asymptomatic; in many cases, infected animals
remain virus carriers for life without exhibiting signs of infection (1, 13). Approximately 30% of
infected cattle develop persistent lymphocytosis (PL), which is characterized by permanent and
relatively stable increases in the number of B lymphocytes in the peripheral blood while resulting
in fatal leukemia or lymphoma in fewer than 5% of the infected cows (5, 6). BLV is transmitted
horizontally through transfer of biological fluids contaminated with BLV-infected B-lymphocytes,
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such as inappropriate re-use of needles and gloves for rectal
examination; through milk; and possibly via insect bites (1, 5).
BLV-infected cows with subclinical mastitis may be sources of
infectious transmission, since these animals produce milk that
contains BLV-infected lymphocytes (14, 15).
Serum ferritin is the best indicator for estimating body iron
stores, whereas serum ferritin provides a marker for malignant
and inflammatory conditions (16). Significantly higher serum
ferritin levels were observed in leukemic cows compared to nor-
mal animals (17). Although BLV-infected dairy cow may appear
healthy, BLV infection may cause economic loss in cattle produc-
tion and export (1, 3, 5, 18). Although the association between
BLV infection and mastitis in dairy cows remains controversial
(14, 15, 19), BLV infection is believed to induce mastitis due to
the virus’ immunosuppressive effects (14). Additionally, serum
iron levels are decreased in animals suffering from inflammatory
diseases, an effect that results from IL-6 mediated hypoferremia
(20). By contrast, serum ferritin can be an inflammatorymarker of
acute-phase infection, although elevated serum ferritin levels can
lead to misdiagnosis of anemia (21). Furthermore, milk ferritin
levels are increased in response to intramammary infection (22).
Despite this previous work in bovids, iron metabolism of
BLV-infected dairy cows has not been studied. There is still
controversial in the relation between BLV-infection and mastitis
(14, 15, 19). Serum ferritinmay be indicator of BLV infection stage
as in tumormarker (23). The purpose of this studywas to elucidate
the effect of BLV infection on iron metabolism in dairy cows.
Materials and Methods
Chemicals
Bovine leukemia antibody test kit was purchased from Japan
New Chisso Corp., Tokyo, Japan. Ferrozine was purchased from
Sigma (St. Louis, MO, USA). Immuno Plate Maxisorp F96, Alka-
line phosphatase (ALP)-conjugated NeutrAvidin, and EZ-link™
sulfo-NHS-biotin were purchased from Thermo Fisher Scientific
(Waltham, MA, USA). Other reagents used were of analytical
grade. Pure water (Elix water) was produced from tap water using
an Elix AdvantageWater Purification System (Millipore, Billerica,
MA, USA).
Blood and Milk from BLV-Infected Dairy Cows
Peripheral blood samples were collected from the jugular veins of
dairy cows on dairy farmsmaintained in the Saitama prefecture of
Japan. All cows including normal dairy cowsmore than 2 years old
were reared to the Japanese feeding standard for dairy cattle but
at different sampling date. Following recovery from centrifuged
coagulated blood, serum was stored at  20°C in the presence of
0.1% sodium azide until analysis. Serum samples were assessed
for the presence anti-BLV antibody by ELISA kit. ELISA titers
(S/P values) were calculated as follows: Absorbances (at 405 nm;
A405) were determined per the kit instructions and corrected by
subtracting background (A405 for reaction wells not coated with
antigen). Corrected A405 values for experimental samples were
normalized against corrected A405 values for the positive control
(hence S/P). BLV-infected cows were identified based on ELISA
titers (S/P values) over 0.3. Milk samples also were collected from
the respective cows, and were defatted by centrifugation prior to
ELISA testing.
All experiments were conducted following the established
guidelines for animal welfare and were approved by the Commit-
tee on the Ethics of Animal Experiments of Kitasato University
(Permit Number: 14-027).
Iron Measurement
Serum and milk samples were diluted twofold with Elix water,
and (for each sample) a 150-µL aliquot was mixed with an equal
volume of a solution of a reducing and iron-dissolving reagent
(2M thioglycolate, 2MHCl, and 10% (w/w) trichloroacetic acid).
The mixture was kept at room temperature for 15min followed
by a centrifugation at 16,000 g for 15min. Each resulting super-
natant (150µL) was neutralized by addition of 150µL of neutral-
izing reagent [30% (w/w) sodium acetate], followed by addition
of 15µL of 10mM ferrozine solution as a chromogen reagent.
After incubation for 30min, the absorbance of the mixture in
each well was measured using a spectrophotometer at a wave-
length of 562 nm. Iron concentration was determined using the
molar extinction coefficient ("mM= 27.9) of the ferrous ferrozine
complex at 562 nm (24).
Ferritin Preparation and Antibodies to Ferritin
Bovine spleen was collected at slaughterhouse and frozen for the
preparation of ferritin until use. Bovine spleen ferritin was puri-
fied from the frozen spleen according to the previously described
method (25). Rabbit antiserum to bovine spleen ferritin was
prepared and partially purified by affinity chromatography as
described previously (25). A portion of the affinity-purified anti-
body to the bovine spleen ferritin was biotinylated with EZ-link™
sulfo-NHS-biotin according to manufacturer’s instructions.
Ferritin Measurement
Ferritin in serum and defatted milk samples was measured by
sandwich ELISA according to a previously described method
(22, 25). Briefly, anti-bovine spleen ferritin antibody (100µL at
200 ng/mL) in phosphate buffered-saline (PBS: 150mM NaCl,
20mM sodium phosphate, pH 7.2) was added to each well of
a microtiter plate. After wells were washed with PBS containing
0.5% Tween 20 (PBST), a 300-µL aliquot of ELISA buffer (PBS
containing 0.1% Tween 20 and 0.1% gelatin, pH 7.2) was added
to each well, and the plate was held at room temperature for 1 h
to block non-specific adsorption of ferritin protein with gelatin.
Following another wash with PBST, 100-µL aliquots of bovine
spleen ferritin standards (0.156–10 ng/mL) in ELISA buffer con-
taining 0.5M (NH4)2SO4 were added, and the plate was incubated
at 37°C for 2 h. Serum and milk samples were diluted 6- or 10-
fold with the same buffer used to prepare the standard solution.
The diluted milk sample was heat-treated at 60°C for 20min fol-
lowed by centrifugation at 14,000 g for 15min, and the resulting
supernatant was used to determine the ferritin concentration as
previously described (22). Aliquots (100µL) of serum samples
and heat-treated milk samples were pipetted to wells of the plate
along with the ferritin standard series. After washing with PBST,
100µL of biotinylated rabbit anti-bovine spleen ferritin antibody
(125 ng/mL) diluted in ELISA buffer was added to each well, and
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TABLE 1 | Age, anamnesis, and ferritin and iron concentrations, and S/P value in serum and milk of BLV-i nfected dairy cows.
Sample no. Age
(year)
Anamnesis Serum Milk
S/P Fe (ppm) Ferritin
(ng/mL)
S/P Fe (ppm) Ferritin
(ng/mL)
1 2.6 1.5 1.4 16 0.3 0.14 1.7
2 2.8 1.7 1.3 54 0.1 0.07 4.9
3 3.5 Injury of parturient canal 2.2 1.6 37 0.8 0.39 1.6
4 3.7 Mastitis 2.7 2.6 23 1.8 0.07 0.8
5 3.8 Mastitis 2.3 1.4 42 1.4 0.35 5.7
6 4.0 Mastitis 2.0 1.9 53 1.2 0.12 13.8
7 4.0 Ketosis, pneumonia 2.8 1.2 42 0.7 0.10 1.3
8 4.2 Mastitis 2.4 1.2 28 1.1 0.24 2.9
9 4.8 Mastitis 2.3 1.2 32 1.1 0.14 1.8
10 4.9 Mastitis, dystocia 2.3 1.8 20 1.4 0.20 1.4
11 5.4 Abomasal displacement, pneumothorax 2.3 2.0 57 0.9 0.20 1.6
12 5.5 Mastitis, ketosis 2.3 1.4 39 NT NT 1.2
13 5.7 Bronchitis 2.8 1.5 62 0.8 0.14 1.0
14 7.4 Dystocia, abomasal displacement 2.2 0.2 53 0.4 0.06 2.3
15 7.8 Mastitis 2.3 1.0 39 1.1 0.41 3.0
MeanSD 4.71.5 2.30.1 1.50.5 4014 0.90.5** 0.20.1* 3.13.4**
* and **: P< 0.01 and P<0.001; significantly different from serum samples, respectively.
NT: not tested.
the plate was incubated at 37°C for 1.5 h. After washing, 100µL of
ALP-conjugated NeutrAvidin (1µg/mL) diluted in ELISA buffer
was added to each well, and the plate was incubated at 37°C for
1.5 h. After washing, the ALP enzyme reaction was carried out
using disodium p-nitrophenyl phosphate as previously described
(25). The concentration of p-nitrophenol produced by the ALP
reaction was determined by measuring the absorbance at 405 nm.
Statistical Analysis
All data obtained are presented as mean SD. The statistical
significance of the differences in means between two groups was
determined by Student’s t-test according to the distribution of
data. A P-value<0.05 was considered significant for all tests.
Results
Effect of BLV Infection on Iron Metabolism in
Dairy Cows
In this study, 15 BLV-infected dairy cows were selected according
to the criteria of antibody titer against gp51 protein by ELISA kit.
The antibody to gp51 antigen also was detected in the 13 milk
samples, all but one of the cows that were BLV-positive by serum
criteria. The antibody titers in the milk specimens were sig-
nificantly lower (P< 0.001) than those in the sera of the BLV-
positive cows (Table 1). The iron and ferritin concentrations in
the milk of these cows also were significantly lower than the
respective values in the sera (P< 0.01 and P< 0.001 in the iron
and ferritin concentrations, respectively). The only significant
correlation observed was that between serum iron concentration
and milk S/P value (Figure 1). No significant difference was
observed in serum ferritin concentrations between BLV-infected
dairy cows (40 14 ng/mL; n= 15) and normal dairy cows older
than 2 years of age (37 5 ng/mL; n= 20). By contrast, milk
ferritin concentrations of BLV-infected cows (3.1 3.4 ng/mL;
FIGURE 1 | Significant correlation between serum iron concentration
and milk S/P value in BLV-infected dairy cows.
n= 14) were significantly lower than those of normal dairy cows
(7.2 5.0 ng/mL; n= 17) (Table 1; Figure 2).
Discussion
Bovine leukemia virus -infected cows often remain asymptomatic
or aleukemic, presumably following establishment of proviral
infection (1, 5, 6). Only one-third of infected cattle develop PL,
a polyclonal expansion of B lymphocytes coexpressing CD5, high
levels of surface immunoglobulinM (sIgM), andmyeloidmarkers
(1, 5–7). In the present study, antibodies to BLV antigen (gp51)
were detected in all but one of the milk samples obtained from
animals that were BLV-positive by serum titers. Notably, however,
antibody titers in the milk of these cows were significantly lower
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FIGURE 2 | Serum and milk ferritin concentrations in normal (solid
boxes) and BLV-infected (solid circles) dairy cows. Serum (n= 20) and
milk (n=15) ferritin concentrations are presented as meanSD from
non-pregnant cows over 2 years old. Serum and milk ferritin concentrations
are plotted as data from individual animals; vertical bars indicate meanSD
(from Table 1). *: P<0.05, compared to normal cows.
than those in the respective sera. BLV particles may be found in
the mammary glands of cows with subclinical mastitis (3, 15).
Moreover, the presence of BLV proteins in the bovine milk exo-
some has been reported to correlate with the presence of anti-
BLV antibodies in the milk (26). BLV-infected cows may release
BLV particles or BLV proteins via the milk, providing a potential
mechanism of BLV transmission. However, further studies will be
needed to determine whether anti-BLV antibodies in the milk are
sufficient to neutralize BLV particles and so prevent transmission
via this biological fluid.
Bovine leukemia virus infection also has been shown to alter
the expression of cytokines such as IL-2, IL-6, IL-10, and IL-12
(1). IL-6 may play a contributory role in viral latency due to
the elevation of its level in blood circulation (1). IL-6 mediates
hypoferremia of inflammation by the reduction of hepcidin,
which in turn causes a decrease in intestinal iron absorption and
the release of iron from macrophages (20). Most BLV-infected
dairy cows exhibit past and present anamnesis, including inflam-
matory disease such as intrammamary disease. Although BLV
infection may affect immune response to pathological agents due
to immunosuppressive effects (1), it remains unclear how BLV
provirus infection is associated with other pathological condi-
tions. However, reports of an association between BLV infection
and mastitis remain controversial (14, 15, 19). Previous reports
indicated that zinc and iron levels inmilkwere significantly higher
in CaliforniaMastitis Test-positive cows than in normal ones (27).
BLV infection may activate cytokine receptor as well as B-cell
growth cytokine (IL-4, IL-6, and IL-10) (11). On the other hand, in
the comparison with previous report (28, 29), we failed to detect a
significant difference in serum or milk iron concentrations when
comparing between BLV-infected and normal dairy cows. Taken
together, mammary gland is likely to affect systemic iron home-
ostasis for unknown reason. High ferritin levels were found in the
sera of cows with leukemia (17). In humans, ferritin can be tumor
marker and factors to monitor the effectiveness of treatment (23).
However, it is unlikely to lead to the increase of serum ferritin
when transformation does not occur. Interestingly, in the present
study, milk ferritin levels were decreased in BLV-infected cows,
even though the infected cows displayed inflammatory conditions
(e.g., intramammary infection). This work also suggested the exis-
tence of a positive correlation between serum iron concentration
and milk S/P value (Figure 1). Although the secretory mecha-
nism of milk ferritin and iron in mammary gland remains to
be resolved for individual viral stages, mammary gland infection
by BLV appears to affect systemic iron homeostasis, seemingly
independent of inflammatory condition, as described above.
Bovine leukemia virus infection can cause immune suppression
in affected animals throughmultiplemechanisms (18). The results
of this study suggest that BLV provirus infection also may disrupt
iron metabolism. Further study will be needed to elucidate the
relationship of iron metabolism between the whole body and the
mammary gland.
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